Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.858 SEK | +3.22% | +0.43% | -53.67% |
03-01 | Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows | MT |
03-01 | Sector Update: Health Care Stocks Edge Higher Premarket Friday | MT |
Sales 2023 | 16.84M 1.54M 123M | Sales 2024 * | 62M 5.67M 454M | Capitalization | 207M 18.89M 1.51B |
---|---|---|---|---|---|
Net income 2023 | -95M -8.68M -695M | Net income 2024 * | -37M -3.38M -271M | EV / Sales 2023 | 15.3 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 3.33 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 23 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 61.03% |
1 day | +3.22% | ||
1 week | +0.43% | ||
Current month | -3.63% | ||
1 month | +1.53% | ||
3 months | -13.78% | ||
6 months | -64.06% | ||
Current year | -53.67% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 31/12/10 | |
Thomas Feldthus
CEO | Chief Executive Officer | 64 | 31/12/10 |
Jørgen Drejer
FOU | Founder | 69 | 31/12/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jørgen Drejer
FOU | Founder | 69 | 31/12/10 |
Director/Board Member | 66 | 31/12/14 | |
Anna Ljung
BRD | Director/Board Member | 44 | 18/01/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.858 | +3.22% | 386,306 |
25/04/24 | 1.8 | +1.24% | 141,042 |
24/04/24 | 1.778 | +0.11% | 202,982 |
23/04/24 | 1.776 | -1.33% | 158,143 |
22/04/24 | 1.8 | -2.70% | 242,598 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:23 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.67% | 18.85M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SANION Stock